LONG-TERM BEVACIZUMAB TREATMENT IN PATIENTS WITH METASTATIC COLORECTAL CANCER WHO ARE RECEIVING FOLFOX4 AND FOLFIRI CHEMOTHERAPY

被引：0
|
作者：
Davidenko, Irina [1 ]
Kazantseva, Margarita [2 ]
Potemin, Sergey [2 ]
Elizbaryan, Karina [2 ]
Mamaeva, Elena [2 ]
Burdik, Oksana [2 ]
机构：
[1] Krasnodar City Oncol Ctr, Krasnodar, Russia
[2] Krasnodar Oncol Ctr, Krasnodar, Russia
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：98 / 98
页数：1
相关论文
共 50 条
  • [1] Erlotinib in combination with bevacizumab and FOLFOX4 as second-line chemotherapy for patients with metastatic colorectal cancer
    Shi, Sha
    Lu, Kemei
    Gao, Hui
    Sun, Huidong
    Li, Senlin
    AMERICAN JOURNAL OF CANCER RESEARCH, 2017, 7 (09): : 1971 - 1977
  • [2] Biweekly Folfox4 and Folfiri in patients with advanced colorectal cancer (ACC)
    Infusino, Stefania
    Gadaleta-Caldarola, Gennaro
    Rea, Antonio
    Filice, Aldo
    Manfredi, Caterina
    Mastroianni, Candida Maria
    Sandomenico, Claudia
    Palazzo, Salvatore
    ANNALS OF ONCOLOGY, 2005, 16 : 45 - 45
  • [3] Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study
    Lievre, Astrid
    Samalin, Emmanuelle
    Mitry, Emmanuel
    Assenat, Eric
    Boyer-Gestin, Christine
    Lepere, Celine
    Bachet, Jean-Baptiste
    Portales, Fabienne
    Vaillant, Jean-Nicolas
    Ychou, Marc
    Rougier, Philippe
    BMC CANCER, 2009, 9 : 347
  • [4] Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study
    Astrid Lièvre
    Emmanuelle Samalin
    Emmanuel Mitry
    Eric Assenat
    Christine Boyer-Gestin
    Céline Lepère
    Jean-Baptiste Bachet
    Fabienne Portales
    Jean-Nicolas Vaillant
    Marc Ychou
    Philippe Rougier
    BMC Cancer, 9
  • [5] First-line therapy for metastatic colorectal carcinoma: modified FOLFOX4 or FOLFIRI-bevacizumab
    Odabas, H.
    Ozdemir, N.
    Abali, H.
    Oksuzoglu, B.
    Isik, M.
    Uncu, D.
    Cihan, S.
    Seker, M.
    Zengin, N.
    JOURNAL OF BUON, 2011, 16 (02): : 247 - 252
  • [6] FOLFOX4 in the treatment of metastatic colorectal cancer in elderly patients: A prospective study
    Berretta, Massimiliano
    Cappellani, Alessandro
    Fiorica, Francesco
    Nasti, Guglielmo
    Frustaci, Sergio
    Fisichella, Rossella
    Bearz, Alessandra
    Talamini, Renato
    Lleshi, Arben
    Tambaro, Rosa
    Cocciolo, Alessandro
    Ristagno, Maurizio
    Bolognese, Antonio
    Basile, Francesco
    Meneguzzo, Nereo
    Berretta, Salvatore
    Tirelli, Umberto
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2011, 52 (01) : 89 - 93
  • [7] Clinical Significance of MMP7 Levels in Colorectal Cancer Patients Receiving FOLFOX4 Chemotherapy Treatment
    Zhou, Yeting
    Wang, Leiming
    Zhou, Fei
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 2671 - 2678
  • [8] Long-term treatment with bevacizumab for patients with metastatic colorectal cancer: Case report
    Hurwitz, Herbert I.
    Honeycutt, Wanda
    Haley, Sherri
    Favaro, Justin
    CLINICAL COLORECTAL CANCER, 2006, 6 (01) : 66 - 69
  • [9] Relationship Between Safety and Cumulative Bevacizumab Dose in Patients With Metastatic Colorectal Cancer Who Received Long-term Bevacizumab Treatment
    Fukuda, Satoshi
    Niisato, Yusuke
    Tsuji, Miki
    Fukuda, Soma
    Hagiwara, Yuya
    Onoda, Tsubasa
    Suzuki, Hirosumi
    Tange, Yoshitaka
    Yamada, Takeshi
    Yamamoto, Yoshiyuki
    Moriwaki, Toshikazu
    ANTICANCER RESEARCH, 2023, 43 (05) : 2085 - 2090
  • [10] EFFICACY OF FOLFOX4 REJIMEN FOR METASTATIC COLORECTAL CANCER
    Ogura, Mariko
    Matsusaka, Satoshi
    Kuboki, Yasutoshi
    Takashi, Ichimura
    Watanabe, Toshiyasu
    Takagi, Kouichi
    Nozaki, Akira
    Ozaka, Masato
    Shinozaki, Eiji
    Suenaga, Mitsukuni
    Chin, Keisyou
    Mizunuma, Nobuyuki
    Hatake, Kiyohiko
    ANNALS OF ONCOLOGY, 2010, 21 : 30 - 30
12345